![Mehis Pold](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Mehis Pold joined CeMines, Inc. in September 2004 as a Director of Development.
He received an MD from Tartu University in 1988.
He has nearly 15 years of experience in cancer research as a Postdoctoral and Junior Faculty Member at UCLA, West Los Angeles VA Hospital and the Burnham Institute.
He became a Junior Faculty Member at Division of Pulmonary and Critical Care Medicine in 2000.
Antiguos cargos conocidos de Mehis Pold.
Empresas | Cargo | Fin |
---|---|---|
CeMines, Inc.
![]() CeMines, Inc. Medical SpecialtiesHealth Technology CeMines, Inc. develops technology for the detection and treatment of cancer. The firm provides diagnostic tests for lung, breast, gastrointestinal, and leukemia. The company was founded by Richard Cavalli, Toomas Neuman and Kaia Palm in 2000 and is headquartered in Golden, CO. | Corporate Officer/Principal | - |
Formación de Mehis Pold.
University of Tartu | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
CeMines, Inc.
![]() CeMines, Inc. Medical SpecialtiesHealth Technology CeMines, Inc. develops technology for the detection and treatment of cancer. The firm provides diagnostic tests for lung, breast, gastrointestinal, and leukemia. The company was founded by Richard Cavalli, Toomas Neuman and Kaia Palm in 2000 and is headquartered in Golden, CO. | Health Technology |
- Bolsa de valores
- Insiders
- Mehis Pold